CD274 and non-small cell lung carcinoma: Previous studies using the anti-PD-L1 clones 28-8, E1L3N, SP263, and 22C3 showed relatively low PD-L1 expression levels in SCLC specimens (5.0‒25.0%) 22-27 compared with those in NSCLC specimens (66.0%) 19.